The Evidence Base Was Built in People Without Diabetes SURMOUNT-1 ran 72 weeks in 2,539 adults with obesity or overweight and excluded diabetes, reporting mean weight changes of 15.0%, 19.5% and 20.9% versus 3.1% with placebo
Common Side Effects Safety Advantages Over Exogenous GH CJC-1295/Ipamorelin has several built-in safety advantages compared to direct GH injections: Pituitary feedback: Your body's somatostatin feedback loop remains active, preventing runaway GH elevation
Masubuchi Y, Nakayama J, Watanabe Y
We applied a previously established summary measure of socioeconomic status (SES) for each U.S
However, these studies excluded patients with a history of major depressive disorder and suicidal ideation, limiting the generalizability of their findings
These additions lack FDA approval for subcutaneous injection, and their effects on tirzepatide absorption, efficacy, and side effect profiles remain unknown